Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel class of HCV protease inhibitors evaluated by Lilly

March 5, 2004

H3 Pharma submits Sanvar IR NDA

March 4, 2004

Enrollment complete in phase IV Visicol constipation study

March 3, 2004

Enzo Biochem acquires OraGen

March 2, 2004

Merck and Isis scientists present new NS5B inhibitors for HCV infection

Feb. 27, 2004

Serono receives rights to InDex's Kappaproct

Feb. 27, 2004

Phase I program commences for HCV-086

Feb. 26, 2004

Entereg receives fast track status for postoperative ileus

Feb. 26, 2004

Nabi reports preliminary results from phase I/II Cicavir study

Feb. 25, 2004

Oral rhIL-11 improves mucosal inflammation in chronic colitis model

Feb. 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...